Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
Shannon Puhalla, Adam BrufskyUPMC Magee-Womens Cancer Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USAAbstract: Taxane therapy is commonly used in the treatment of metastatic breast cancer. However, most patients will eventually become refractory to these agents. Ixabepilone is a new...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-09-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/ixabepilone-a-new-chemotherapeutic-option-for-refractory-metastatic-br-a2300 |